20 results on '"Tae, Nara"'
Search Results
2. IL-7-primed bystander CD8 tumor-infiltrating lymphocytes optimize the antitumor efficacy of T cell engager immunotherapy
3. 837 Redirecting IL-7-induced bystander tumor-infiltrating lymphocytes by bispecific T-cell engager augments antitumor response
4. Bispecific Antibody-Bound T Cells as a Novel Anticancer Immunotherapy
5. Development of Bispecific Antibody for Cancer Immunotherapy: Focus on T Cell Engaging Antibody
6. Anti-inflammatory and heme oxygenase-1 inducing activities of lanostane triterpenes isolated from mushroom Ganoderma lucidum in RAW264.7 cells
7. The anti-inflammatory effect of 3-deoxysappanchalcone is mediated by inducing heme oxygenase-1 via activating the AKT/mTOR pathway in murine macrophages
8. Malabaricone C suppresses lipopolysaccharide-induced inflammatory responses via inhibiting ROS-mediated Akt/IKK/NF-κB signaling in murine macrophages
9. 450 Combination of rhIL-7-hyFc and anti-PD-L1xCD3ε bispecific antibody enhances antitumor response in mice
10. BLI-Based Functional Assay in Phage Display Benefits the Development of a PD-L1-Targeting Therapeutic Antibody
11. Novel Antibodies Targeting MUC1-C Showed Anti-Metastasis and Growth-Inhibitory Effects on Human Breast Cancer Cells
12. Eupatolide inhibits lipopolysaccharide-induced COX-2 and iNOS expression in RAW264.7 cells by inducing proteasomal degradation of TRAF6
13. A cassaine diterpene alkaloid, 3β-acetyl-nor-erythrophlamide, suppresses VEGF-induced angiogenesis and tumor growth via inhibiting eNOS activation
14. Syntenin promotes VEGF-induced VEGFR2 endocytosis and angiogenesis by increasing ephrin-B2 function in endothelial cells
15. Cassaine diterpene alkaloids from Erythrophleum fordii and their anti-angiogenic effect
16. Abstract 1055: Syntenin positively regulates TGF-β1- and oncogenic Ras-mediated EMT-like phenotypic changes in cancer cells
17. ChemInform Abstract: Cassaine Diterpene Alkaloids from Erythrophleum fordii and Their anti-Angiogenic Effect.
18. Corrigendum to “Eupatolide inhibits lipopolysaccharide-induced COX-2 and iNOS expression in RAW264.7 cells by inducing proteasomal degradation of TRAF6” [Eur. J. Pharmacol. 636 (2010) 173–180]
19. Erratum to "Bispecific Antibody-Bound T Cells as a Novel Anticancer Immunotherapy" [Biomol. Ther. 30 (2022) 418-426].
20. 3-Oxoolean-12-en-27-oic acid inhibits the proliferation of non-small cell lung carcinoma cells by inducing cell-cycle arrest at G0/G1 phase.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.